Université Paris-Saclay and its partners at Viva Technology 2026

A major international event, Viva Technology brings together innovations and transformations addressing today’s and tomorrow’s key societal, environmental, economic, and human challenges.

At its stand, 3H19, Université Paris-Saclay will this year be joined by Université d'Évry and UVSQ, associated member universities, the four Grandes Écoles AgroParisTech, CentraleSupélec, École normale supérieure Paris-Saclay, Institut d'Optique Graduate School, two national research partner organizations INRAE and Inria, as well as the incubator IncubAlliance Paris-Saclay, SATT Paris-Saclay, and the artificial intelligence research institute DATAIA. Several start-ups from the university community and the Paris-Saclay territory will also be present at the stand.

At the heart of a technology cluster representing 13% of French R&D, Université Paris-Saclay, the leading university in France and among the global Top 20, has chosen to place innovation at the core of its strategy, alongside research and education, fully integrating it into its missions.

The university leads the university innovation hub (PUI) Innovation Alliance Université Paris-Saclay, certified in July 2023 and bringing together Université Paris-Saclay, Université d'Évry, Université de Versailles - Saint-Quentin-en-Yvelines (UVSQ), AgroParisTech, CentraleSupélec, ENS Paris-Saclay, Institut d’Optique Graduate School, CNRS, INRAE, Inria, Inserm, IncubAlliance Paris-Saclay, and SATT Paris-Saclay, and funded by the State under France 2030. For the third consecutive year since the PUI’s certification, Viva Technology will be a new opportunity for the university to strengthen the PUI’s reputation and increase its international visibility.

Stay tuned for information on the start-ups that will be present at the stand throughout the four days of the event.

Start-up exhibiting on Wednesday 17 June:

Diagante, spun out of the Infection and Inflammation laboratory (2I – Univ. Paris-Saclay/Inserm/UVSQ) and co-founded in 2020 by Martin Rottman (CSO), a specialist in medical biology at Raymond Poincaré Hospital and professor of microbiology at UVSQ, Cécile Chevalier (CEO) and Virginie Lebidois (COO). Diagante is a medtech company spun out of UVSQ and AP-HP that develops medical devices to harness the potential of solid biopsies and improve the detection of microorganisms as well as diagnostic precision. Its product TISSUtainer®, which is CE and UKCA marked, preserves and processes samples immediately upon collection and is already in use in several major hospitals in France.

Exhalon, spun out of the Infection and Inflammation Laboratory (2I – Univ. Paris-Saclay/Inserm/UVSQ) and co-founded in 2025 by Stanislas Grassin Delyle (CSO), a 
researcher at the Infection and Inflammation Laboratory, Cécile Chevalier (CEO), Elyas Fayad (CTO) and Camille Roquencourt (AI lead). Exhalon is developing a medical diagnostic platform based on the analysis of exhaled air. By combining mass spectrometry and artificial intelligence, its technology enables rapid, reliable and non-invasive diagnosis of respiratory diseases in under one minute. This platform paves the way for numerous future applications, from screening through to the monitoring of multiple conditions. The start-up is supported by the Paris-Saclay public deeptech incubator, IncubAlliance Paris-Saclay.

SP3D, founded in 2018 by Paul Guillaumot, has developed THEIA, a platform that enables the automatic reconstruction of 3D models from engineering drawings (2D). The start-up is notably in partnership with the University Research Laboratory for Automated Production (Lurpa – Univ. Paris-Saclay/ENS Paris-Saclay).

Surus Connect, founded in 2025 by Eliot Dupré, enhances the concept of the LWAL (Lone Worker Alarm System) to ensure the safety of rural workers. Using patented technology, Surus Connect independently identifies workplace incidents using machine learning algorithms to trigger SOS alerts and/or shut down machinery remotely. Surus Connect also incorporates risk mapping and awareness-raising features. It is supported by AgroParisTech’s Farm’Inn Lab, a space for experimentation and collaboration in agricultural innovation.

Willis, founded in 2026 by Nabil Zerrari (CEO) and Vincent Vigneron (CSO), a professor at Paris-Saclay University, and emerging from a university-hospital programme bringing together the Laboratory of Computer Science, Bioinformatics and Complex Systems (Ibisc – Paris-Saclay University/University of Évry) and the Centre hospitalier sud francilien (CHSF). The start-up develops intelligent technological building blocks to assist neuroradiologists in detecting lesions in patients who have suffered acute or subacute strokes, as well as in predicting clinical prognosis and response to treatment. It is supported by IncubAlliance Paris-Saclay and SATT Paris-Saclay.

Wingleet, founded in 2025 by a CentraleSupélec alumnus, Sébastien Batty. It is developing an AI agent that is revolutionising aircraft maintenance. From the automatic analysis of technical documents to assisting technicians in the field, the platform makes aircraft maintenance faster, safer and smarter, ensuring that every aircraft remains in service for as long as possible. It is supported by the 21st by CentraleSupélec accelerator.

Start-up exhibiting on Thursday 18 June:

Carembouche, co-founded in 2021 by Muriel Thomas, INRAE Research Director, Francisca Joly and Odile de Christen, is an INRAE spin-off from the Food Microbiology Laboratory for Human Health (MICALIS – Univ. Paris-Saclay/INRAE/AgroParisTech) and winner of the Bpifrance i-LAB Innovation Award in 2023. It translates knowledge of the microbiome into clinical nutrition. By 2030, the market is estimated to be worth $19 billion, with growth expected due to an ageing population. The first product developed by the start-up is the only oral nutritional supplement rich in protein, energy and probiotics, designed specifically for malnourished adults. The start-up has been supported by SATT Paris-Saclay, IncubAlliance Paris-Saclay and AgroParisTech.

Luxoderm, which emerged from research conducted at the Charles Fabry Laboratory (LCF – Univ. Paris-Saclay/CNRS/Institut d’Optique Graduate School) and co-founded by Anthony Donabedian, Louis Dorlencourt, alumni of the Institut d’Optique Graduate School, and Yaelle Dubois. The start-up develops WoundLight, a medical device intended for healthcare professionals for the treatment of chronic wounds. Based on patented luminescent concentrator technology, WoundLight emits specific spectra capable of modulating key biological mechanisms of wound healing and accelerating the process, in a non-invasive and contact-free manner. The start-up is supported by the 21st by CentraleSupélec accelerator and CNRS Innovation (CNRS: French National Centre for Scientific Research).

Safenai, co-founded in 2025 by Julien Chiaroni (CEO), Loic Cantat (CTO) and Fabien Tschirhart (CPO), and originating from the Laboratory for Systems and Technology Integration (List – Univ. Paris-Saclay/CEA) and IRT SystemX. Safenai transforms ‘black box’ AI into controlled industrial assets. Its Klarity platform monitors and manages AI models in production to detect deviations and ensure reliable performance. This approach thus secures deployments across business operations, ensuring ROI, compliance and effective operational adaptation. The start-up is supported by IncubAlliance Paris-Saclay.

Scientalab, co-founded in 2021 by Camille Bouget, Vincent Bouget and Julien Duquesne, all alumni of CentraleSupélec, is a tech-bio company developing computational models of human immunology and diseases to improve drug development. Its EVA platform simulates biological responses to help pharmaceutical and biotechnology companies select targets, prioritise indications and identify responsive patients. The start-up is supported by the DataIA Paris-Saclay Institute, the 21st by CentraleSupélec accelerator, and in partnership with the Mathematics and Computer Science for Complexity and Systems Laboratory (Mics – Univ. Paris-Saclay/CentraleSupélec).

SQY Therapeutics, founded in 2015 by Luis Garcia and spun out of the Neuromuscular Disability Unit: Pathophysiology, Biotechnology and Applied Pharmacology (END-ICAP – Univ. Paris-Saclay/UVSQ/Inserm), is a French biotech company developing innovative antisense oligonucleotide (ASO) therapies to treat rare genetic diseases. Its unique technology specifically targets Duchenne muscular dystrophy, with its drug candidate SQY51 currently in clinical trials.

Zoe Care, co-founded in 2022 by Thomas Saphir (CEO), a CentraleSupélec alumnus, and Piotr Antonik (CTO), lecturer and researcher at CentraleSupélec, and originating from research conducted at the Mathematics and Computer Science for Complexity and Systems laboratory (Mics – Univ. Paris-Saclay/CentraleSupélec), transforms the homes of elderly people into safer environments using AI-powered detection. Its patented technology, developed with CentraleSupélec, analyses micro-movements to detect falls and unusual activities in real time, without cameras or wearable devices. A discreet solution that preserves privacy, alerts carers quickly, and extends independence at home. It is supported by SATT Paris-Saclay (SATT: Technology Transfer Acceleration Company) and the 21st by CentraleSupélec accelerator.

Start-up exhibiting on Friday 19 June:

Orasuna, co-founded in 2026 by Christine Delorme, Véronique Douard, Vincent Juillard, researchers at INRAE, Séverine Layec, lecturer and researcher at AgroParisTech, and Pascal Leuraud, and originating from the Food Microbiology for Human Health laboratory (Micalis – Univ. Paris-Saclay/INRAE/AgroParisTech). This start-up is revolutionising the prevention of metabolic diseases through innovative, non-pharmaceutical solutions inspired by the gut microbiota. Our products act effectively and rapidly on blood glucose regulation, offering people with prediabetes the means to regain control of their health and prevent progression to type 2 diabetes. It is supported by SATT Paris-Saclay.

Billa training is a research and innovation organisation created in 2014 by Véronique Billat, professor at the Université d’Évry, and originating from research carried out at the Computer Science, Bioinformatics and Complex Systems laboratory (Ibisc – Univ. Paris-Saclay/Univ. d’Évry), in collaboration with the Signal, Image and Automation (Siam) team. It develops assessment protocols and smart sensors for human training and animal welfare, including a harness with force sensors and a training assistance algorithm.

Blur Labs, founded in 2026 by Matthieu Terris, former researcher at Inria Saclay and alumnus of the Université Paris-Saclay, and originating from the research work of the Mind project team, a joint initiative between Inria and the CEA Paris-Saclay NeuroSpin centre, develops foundation models for medical image restoration. These models help reduce acquisition times across multiple modalities (MRI, CT, SPECT, PET), reducing patient discomfort while improving image quality and diagnostic performance.

Ethylowheel, co-founded in 2022 by Jaime Alonso (CEO), alumnus of the Institut d’Optique Graduate School, and Julie Bruguière (COO), alumna of. It develops innovative alcohol detection solutions via skin contact, based on analysis of gases emitted by the skin. Its technology enables rapid and discreet estimation of blood alcohol levels. EthyloKey is a connected keyring that uses a colour code system to indicate whether the user is fit to drive. The start-up is supported by IncubAlliance Paris-Saclay.

MS Insight, co-founded in 2022 by Arnaud Cutivet and Toky Ratovomanana, develops MSIcare, an AI-powered medical device software that detects microsatellite instability (MSI), a DNA alteration predicting response to immunotherapy. Drawing on 20 years of expertise acquired by its co-founders at Inserm and AP-HP (Assistance Publique – Hôpitaux de Paris, Paris public hospital system), it supports oncologists in clinical decision-making through more reliable diagnostics, enabling access to life-saving treatments. The mission of MS Insight is to put precision diagnostics at the service of precision medicine. It is supported by the 21st by CentraleSupélec accelerator.

Mycelium technologies, co-founded in 2022 by Laetitia Pierazzi, Jaafar Kilani, alumni of Université Paris-Saclay, and Olivier Hiezely, was born in the laboratories of Évry-Courcouronnes within the Genopole incubator. MYCTECHS develops Mynion, a new food product based on mycelium, produced through solid-state fermentation on plant substrates. Naturally fibrous, clean-label and local, it enables the creation of gourmet, sustainable and accessible dishes, from savoury to sweet, without extrusion or ultra-processing. The start-up is supported by IncubAlliance Paris-Saclay and Genopole.

Start-up exhibiting on Saturday 20 June:

Learning robots, founded in 2020 by Thomas Deneux, neuroscientist at the Paris-Saclay Institute of Neuroscience (NeuroPSI – Univ. Paris-Saclay/CNRS), is a company offering software and a robot (AlphAI) to teach the fundamentals of AI (machine learning, neural networks, Python coding) in a fun and progressive way in companies and universities. The company runs numerous AI awareness workshops in companies, using team-building sessions based on autonomous robot racing. It is supported by the DataIA Institute and the CNRS.

The Filiale spatiale project, developed at the Laboratory of Atmospheres, Observations and Space (Latmos – Univ. Paris-Saclay/UVSQ/Sorbonne University/CNRS) by Mustapha Meftah and his team. The UVSQ nanosatellite programme is based on three dimensions: educational, technological and scientific, and also involves close collaboration with the Île-de-France Space Academy. Three satellites have already been launched into orbit: UVSQ-SAT in 2021, INSPIRE-Sat 7 in 2023 and UVSQ-SAT NG in 2025. 
 

Next Startupper Award: a competition for young entrepreneurs

Viva Technology organises an annual competition for students and doctoral candidates who wish to become entrepreneurs: the Next Startupper Award.

Finalists will have the opportunity to present their project on stage at VivaTech, in front of leaders from the tech and entrepreneurship sectors.

The winner will receive a prize of €5,000 as well as a start-up corner at VivaTech 2027.

Eligibility criteria:

• Be a student or doctoral candidate
• Have a project or start-up created less than three years ago
• Be proficient in English
• Develop a project with a positive impact on the planet and/or society
• Incorporate a technological dimension
• Be available in Paris from 17 to 19 June 2026

The application deadline is Tuesday, 10 March 2026.

For more information and to apply - Next Startupper Award 2026 : https://challenges.vivatechnology.com/en/challenges/next-startupper-award